HOME Top Market Reports Ablation Technology Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal) & Application (Cardiovascular, Cancer, Pain Management, Orthopedics) - Global Forecasts to 2021

Ablation Technology Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal) & Application (Cardiovascular, Cancer, Pain Management, Orthopedics) - Global Forecasts to 2021

By: marketsandmarkets.com
Publishing Date: February 2017
Report Code: MD 2738

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The ablation technologies market is expected to reach USD 4.73 Billion by 2021 from USD 2.82 Billion in 2016, at a CAGR of 10.9% during the forecast period. Rising incidence of cancer and prevalence of cardiovascular diseases are the major factors driving the growth of this market. In addition, increasing number of ablation procedures, hospitals, surgical, and ablation centres and emergence of next-generation ablation products and technologies are further aiding to the growth prospects of this market. However, reuse and reprocessing of devices in developing countries and healthcare cost-containment measures taken in a number of developed countries can hinder the growth of this market.

Increasing focus of global players towards developing nations, notable mergers and acquisitions in microwave ablation segment, and development of advanced radiofrequency ablation devices are the major trends in the ablation technologies market. Key players in the ablation technologies market are acquiring small ablation devices companies expand their ablation device businesses across the globe. Few significant mergers and acquisitions in this segment include; acquisition of - Dfine, Inc. (U.S.) by Merit Medical Systems, Inc. (U.S.) in July 2016; Galil Medical Inc. (U.S.) by BTG plc (U.K.) in June 2016; NeuWave Medical Inc (U.S.) by Johnson & Johnson (U.S.) in April 2016; Covidien plc (Ireland) by Medtronic, Inc (U.S.) in January 2015; and Microsulis Medical Ltd. (U.K.) by AngioDynamics, Inc. (U.S.) in February, 2013, among others.

The rising incidence of cancer and aging population across the globe are further aiding the market growth as global cancer patient population forms the major target market for ablation products as key ablation technologies are used for treatment and management of various tumor/cancers in the liver, lung, kidney, breast, and prostate. Additionally, risk of cancer increases with age. Approximately 60% of patients who have cancer are aged 65 and above (Source: American Society of Clinical Oncology). According to the United Nations Department of Economic and Social Affairs, the population of individuals aged above 65 years represented 9.2% of the global population in 1990. This figure reached 11.7% by 2013 and is further expected to increase to 21.1% by 2050. In order to meet the demand for the cancer treatment, major players are focusing on bringing in advanced ablation products in the market. For instance, Medtronic, a leading player in ablation technology, launched OsteoCool RF Ablation System to treat spine metastases, in January 2016. The system destroys cancer cells by using highfrequency energy, and also provides procedural flexibility and tailored treatment for spine metastases.

This report broadly segments the global ablation technologies market into type, application, and product. The ablation technologies market, by type is segmented into laser/light, radiofrequency, ultrasound, electrical, cryoablation, microwave, and hydrothermal ablation technology. The market by application cosmetic surgery, cardiovascular disease treatment, pain management, cancer treatment, ophthalmology, gynaecology, urology, orthopaedics, and others. The cardiovascular disease treatment segment is expected to command a major share of the ablation technologies market in 2016. On the basis of products, the ablation technologies market is segmented into light/laser ablators, radiofrequency ablators, ultrasound ablators, electrical ablators, cryoablation devices, microwave ablators, and hydrothermal ablators. The microwave ablators segment is estimated to grow at the highest CAGR during 2016 to 2021.

Geographically, the global ablation technologies market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America (comprising the U.S. and Canada) commanded a major share of the ablation technologies market. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the growing focus of global market players, large population base, improving healthcare infrastructure facilities, and the rising prevalence of cancer.

Medtronic, Inc. (U.S.), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.), AtriCure, Inc. (U.S.), Smith & Nephew plc (U.K.), and Olympus Corporation (Japan) are some of the key players in the ablation technologies market.

Target Audience:

  • Ablation Device Manufacturing Companies
  • Healthcare Institutions (Hospitals and Outpatient Clinics)
  • Distributors and Suppliers
  • Research Institutions
  • Market Research and Consulting Firms
  • Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the ablation technologies market into the following segments and subsegments:

Global Ablation Technologies Market, by Type

  • Radiofrequency
  • Laser/Light
  • Ultrasound
  • Electrical
  • Cryoablation
  • Microwave
  • Hydrothermal

Global Ablation Technologies Market, by Product

  • Radiofrequency Ablators
    • Temperature-controlled Radiofrequency Ablators
    • Fluid-cooled Radiofrequency Ablators
    • Robotic Catheter Manipulation Systems
  • Laser/Light Ablators
    • Excimer Laser Ablators
    • Cold Laser Ablators
  • Ultrasound Ablators
    • High-intensity Focused Ultrasound (HIFU) Ablators
    • Magnetic Resonance-guided Focused Ultrasound (MRGFUS) Ablators
    • Ultrasonic Surgical Ablation Systems
    • Extracorporeal Shockwave Lithotripsy (ESWL) Systems
  • Electrical Ablators
    • Argon Plasma/Beam Coagulators
    • Irreversible Electroporation Ablators
  • Cryoablation Devices
    • Tissue Contact Probes
    • Tissue Spray Probes
    • Epidermal And Subcutaneous Cryoablation Devices
  • Microwave Ablators
    • Microwave Thermotherapy Devices
  • Hydrothermal Ablators
    • Endometrial Hydrothermal Balloon Ablation Devices

Global Ablation Technologies Market, by Application

  • Cardiovascular Disease
  • Cancer
  • Ophthalmology
  • Pain Management
  • Gynecology
  • Urology
  • Orthopedic Treatment
  • Cosmetic Surgery
  • Others

Others include fecal incontinence, gastroesophageal reflux disease (GERD), tonsillectomy, psoriasis, wound management, obstructive sleep apnea, and port wine stains.

Global Ablation Technologies Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World

Available Customization

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific ablation technologies market into South Korea, Australia, New Zealand, and Others
  • Further breakdown of the Rest of the World ablation technologies market into Latin America, Middle East, and Africa

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
           1.4.1 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Methodology Steps
    2.2 Research Design
    2.3 Secondary and Primary Research Methodology
           2.3.1 Secondary Research
                    2.3.1.1 Key Data From Secondary Sources
           2.3.2 Primary Research
                    2.3.2.1 Key Data From Primary Sources
           2.3.3 Market Size Estimation Methodology
    2.4 Opportunity Indicators
           2.4.1 Demand-Side Analysis
                    2.4.1.1 Incidence and Prevalence of Cancer
                    2.4.1.2 Rapid Growth of Geriatric Population
                    2.4.1.3 Significant Number of Clinical Researches in Ablation
           2.4.2 Supply-Side Analysis
                    2.4.2.1 Clinical Trials By Ablation Technology
                    2.4.2.2 Number of New Product Launches: Ablation Market (2013–2016)
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 34)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 38)
    4.1 Global Ablation Technology Market Overview
    4.2 Geographical Snapshot of the Global Ablation Technology Market
    4.3 Global Ablation Technology Market, By Type and Region
    4.4 Global Ablation Technology Market, By Application
    4.5 Global Ablation Technology Market Size, By Product (2016 vs 2021)

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Emergence of Next-Generation Ablation Products and Technology
                    5.2.1.2 Rising Incidence of Cancer
                    5.2.1.3 Growing Prevalence of Cardiovascular Diseases
                    5.2.1.4 Increasing Number of Ablation Procedures
                    5.2.1.5 Increasing Number of Hospitals, Surgical, and Ablation Centers
           5.2.2 Restraints
                    5.2.2.1 Reuse and Reprocessing of Devices in Developing Countries
                    5.2.2.2 Healthcare Cost-Containment Measures
                    5.2.2.3 Unfavorable Regulatory Scenario
           5.2.3 Opportunities
                    5.2.3.1 Growth Potential Offered By Emerging Markets
                    5.2.3.2 Rising Awareness Related to Ablation Procedures
           5.2.4 Challenges
                    5.2.4.1 Product Recalls
                    5.2.4.2 Therapeutic Challenges

6 Industry Trends (Page No. - 50)
    6.1 Key Industry Trends: Ablation Market
           6.1.1 Industry Consolidation
           6.1.2 Increasing Focus of Global Players Towards Developing Nations
           6.1.3 Increasing Funding for Ablation Product Development and Commercialization
           6.1.4 Notable Developments in Microwave Ablation Segment
           6.1.5 High Focus of Market Players Towards Development of Advanced Radiofrequency Ablation Devices
    6.2 Reimbursement Scenario (Qualitative Insights)
    6.3 Supply Chain Analysis
    6.4 Porter’s Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat of Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 Global Ablation Technology Market, By Type (Page No. - 60)
    7.1 Introduction
    7.2 Radiofrequency Ablation
    7.3 Laser/Light Ablation
    7.4 Ultrasound Ablation
    7.5 Electrical Ablation
    7.6 Cryoablation
    7.7 Microwave Ablation
    7.8 Hydrothermal Ablation

8 Global Ablation Technology Market, By Product (Page No. - 72)
    8.1 Introduction
    8.2 Radiofrequency Ablators
           8.2.1 Temperature-Controlled Radiofrequency Ablators
           8.2.2 Fluid-Cooled Radiofrequency Ablators
           8.2.3 Robotic Catheter Manipulation Systems
    8.3 Laser/Light Ablators
           8.3.1 Excimer Laser Ablators
           8.3.2 Cold Laser Ablators
    8.4 Ultrasound Ablators
           8.4.1 Ultrasonic Surgical Ablation Systems
           8.4.2 High-Intensity Focused Ultrasound (HIFU) Ablators
           8.4.3 Extracorporeal Shockwave Lithotripsy (ESWL) Systems
           8.4.4 Magnetic Resonance-Guided Focused Ultrasound (MRGFUS) Ablators
    8.5 Electrical Ablators
           8.5.1 Argon Plasma/Beam Coagulators
           8.5.2 Irreversible Electroporation Ablators
    8.6 Cryoablation Devices
           8.6.1 Tissue Contact Probes
           8.6.2 Tissue Spray Probes
           8.6.3 Epidermal and Subcutaneous Cryoablation Devices
    8.7 Microwave Ablators
           8.7.1 Microwave Thermotherapy Devices
    8.8 Hydrothermal Ablators
           8.8.1 Endometrial Hydrothermal Balloon Ablation Devices

9 Global Ablation Technology Market, By Application (Page No. - 93)
    9.1 Introduction
    9.2 Cardiovascular Disease Treatment
    9.3 Cancer Treatment
           9.3.1 Liver Cancer
           9.3.2 Kidney Cancer
           9.3.3 Prostate Cancer
           9.3.4 Lung Cancer
           9.3.5 Bone Metastasis
           9.3.6 Breast Cancer
    9.4 Ophthalmologic Treatment
    9.5 Pain Management
    9.6 Gynecological Treatment
    9.7 Urological Treatment
    9.8 Orthopedic Treatment
    9.9 Cosmetic/ Aesthetic Surgery
    9.10 Other Treatments

10 Global Ablation Technology Market, By Region (Page No. - 109)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
                        10.2.1.1 Significant Volume of Ablation Procedures in the Country
                        10.2.1.2 Remarkable Adoption of Advanced Ablation Technology as Compared to Conventional Technology
                        10.2.1.3 Availability of Funding for Development of Novel Ablation Devices
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Rising Focus of Market Players
                        10.3.1.2 Large Number of Ongoing Clinical Trials
                        10.3.1.3 Favorable Healthcare Reimbursement Scenario
                        10.3.1.4 Growing Incidence of Cancer and Cardiovascular Diseases
             10.3.2 France
                        10.3.2.1 Availability of Funding for Development of Novel Ablation Devices in the Country
                        10.3.2.2 Availability of Training Programs and Reimbursement for Certain Products in France
             10.3.3 U.K.
                        10.3.3.1 Large Patient Population Base
                        10.3.3.2 Availability of Research Funding
                        10.3.3.3 Expanding Presence of Market Players
                        10.3.3.4 Government Recommendations Encouraging Adoption of Ablation Technology
             10.3.4 Rest of Europe
                        10.3.4.1 Rapidly Increasing Aging Population in the Region
                        10.3.4.2 Increasing Market Penetration of Leading Ablation Manufacturers in the Region
                        10.3.4.3 Prominent Adoption of Ablation in Italy
     10.4 Asia-Pacific
             10.4.1 Increasing Government Initiatives in the Region
                        10.4.1.1 Awareness Programs and Conferences in APAC
                        10.4.1.2 Rising Focus of Market Players
             10.4.2 Japan
                        10.4.2.1 Well-Developed Healthcare System
                        10.4.2.2 Rising Baby Boomer Population Coupled With Cancer Incidence in the Country
                        10.4.2.3 Rising Government Focus Towards the Development of the Medical Device Industry
             10.4.3 China
                        10.4.3.1 High Incidence of Target Diseases and Rapidly Aging Population
             10.4.4 India
                        10.4.4.1 Remarkable Patient Base in the Country
                        10.4.4.2 Improving Healthcare Infrastructure in the Country
                        10.4.4.3 Rising Focus of Global Players
             10.4.5 Rest of Asia-Pacific
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 143)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Situation and Trends
             11.3.1 New Product Launches & Approvals
             11.3.2 Mergers & Acquisitions
             11.3.3 Geographical Expansions
             11.3.4 Agreements and Joint Ventures
             11.3.5 Other Developments

12 Company Profiles (Page No. - 151)
(Overview, Products and Services, Financials, Strategy & Development)*
     12.1 Introduction
     12.2 Medtronic PLC
     12.3 Biosense Webster, Inc. (A Subsidiary of Johnson & Johnson Inc.)
     12.4 St. Jude Medical, Inc.
     12.5 Boston Scientific Corporation
     12.6 Angiodynamics, Inc.
     12.7 Atricure, Inc.
     12.8 Conmed Corporation
     12.9 Olympus Corporation
     12.10 Smith & Nephew
     12.11 Galil Medical Inc. (Acquired By BTG International Ltd.)

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 185)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (76 Tables)

Table 1 Clinical Research Status By Ablation Technology as of 2017*
Table 2 Major Merger & Acquisition Activities in the Ablation Technology Industry (2013–2016)
Table 3 Global Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 4 Ablation Technology Market Size, By Region, 2014–2021 (USD Million)
Table 5 Radiofrequency Ablation Market Size, By Region, 2014–2021 (USD Million)
Table 6 Laser/Light Ablation Market Size, By Region, 2014–2021 (USD Million)
Table 7 Ultrasound Ablation Market Size, By Region, 2014–2021 (USD Million)
Table 8 Electrical Ablation Market Size, By Region, 2014–2021 (USD Million)
Table 9 Cryoablation Market Size, By Region, 2014–2021 (USD Million)
Table 10 Microwave Ablation Market Size, By Region, 2014–2021 (USD Million)
Table 11 Hydrothermal Ablation Market Size, By Region, 2014–2021 (USD Million)
Table 12 Global Ablation Technology Market Size, By Product, 2014–2021 (USD Million)
Table 13 Radiofrequency Ablators Market Size, By Product, 2014–2021 (USD Million)
Table 14 Radiofrequency Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 15 Temperature-Controlled Radiofrequency Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 16 Fluid-Cooled Radiofrequency Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 17 Robotic Catheter Manipulation Systems Market Size, By Region, 2014–2021 (USD Million)
Table 18 Laser/Light Ablators Market Size, By Product, 2014–2021 (USD Million)
Table 19 Laser/Light Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 20 Excimer Laser Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 21 Cold Laser Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 22 Ultrasound Ablators Market Size, By Product, 2014–2021 (USD Million)
Table 23 Ultrasound Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 24 Ultrasonic Surgical Ablation Systems Market Size, By Region, 2014–2021 (USD Million)
Table 25 High-Intensity Focused Ultrasound Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 26 Extracorporeal Shockwave Lithotripsy Systems Market Size, By Region, 2014–2021 (USD Million)
Table 27 Magnetic Resonance-Guided Focused Ultrasound Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 28 Electrical Ablators Market Size, By Product, 2014–2021 (USD Million)
Table 29 Electrical Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 30 Argon Plasma/Beam Coagulators Market Size, By Region, 2014–2021 (USD Million)
Table 31 Irreversible Electroporation Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 32 Cryoablation Devices Market Size, By Product, 2014–2021 (USD Million)
Table 33 Cryoablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table 34 Tissue Contact Probes Market Size, By Region, 2014–2021 (USD Million)
Table 35 Tissue Spray Probes Market Size, By Region, 2014–2021 (USD Million)
Table 36 Epidermal and Subcutaneous Cryoablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table 37 Microwave Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 38 Hydrothermal Ablators Market Size, By Region, 2014–2021 (USD Million)
Table 39 Global Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
Table 40 Ablation Technology Market Size for Cardiovascular Disease Treatment, By Region, 2014–2021 (USD Million)
Table 41 Ablation Technology Market Size for Cancer Treatment, By Region, 2014–2021(USD Million)
Table 42 Ablation Technology Market Size for Ophthalmologic Treatment, By Region, 2014–2021 (USD Million)
Table 43 Ablation Technology Market Size for Pain Management, By Region, 2014–2021 (USD Million)
Table 44 Currently Approved Fda Ablation Technologies for Gynecological Treatment
Table 45 Ablation Technology Market Size for Gynecological Treatment, By Region, 2014–2021 (USD Million)
Table 46 Ablation Technology Market Size for Urologic Treatment, By Region, 2014–2021(USD Million)
Table 47 Ablation Technology Market Size for Orthopedic Treatment, By Region, 2014–2021 (USD Million)
Table 48 Ablation Technology Market Size for Cosmetic/ Aesthetic Surgery, By Region, 2014–2021 (USD Million)
Table 49 Ablation Technology Market Size for Other Treatments, By Region, 2014–2021 (USD Million)
Table 50 Global Ablation Technology Market Size, By Region, 2014–2021 (USD Million)
Table 51 North America: Ablation Technology Market Size, By Country, 2014–2021 (USD Million)
Table 52 North America: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 53 North America: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
Table 54 U.S.: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 55 Canada: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 56 Europe: Ablation Technology Market Size, By Country, 2014–2021 (USD Million)
Table 57 Europe: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 58 Europe: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
Table 59 Germany: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 60 France: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 61 U.K.: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 62 Rest of Europe: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 63 Asia-Pacific: Ablation Technology Market Size, By Country, 2014–2021 (USD Million)
Table 64 Asia-Pacific: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 65 Asia-Pacific: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
Table 66 Japan: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 67 China: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 68 India: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 69 Rest of APAC: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 70 RoW: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 71 RoW: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
Table 72 Top 5 New Product Launches & Approvals, 2012–2015
Table 73 Mergers & Acquisitions, 2013–2016
Table 74 Geographical Expansions, 2014–2016
Table 75 Top 3 Agreements and Joint Ventures, 2013–2015
Table 76 Top 5 Other Developments, 2014–2016


List of Figures (43 Figures)

Figure 1 Global Ablation Technology Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Research Methodology: Top-Down Approach
Figure 4 Research Methodology: Bottom-Up Approach
Figure 5 Estimated Number of New Cancer Cases, By 2020 (Thousands)
Figure 6 Population Aged 65 and Above, By Region (In Million): 2015, 2030, and 2050
Figure 7 Clinical Research Status in the Ablation Market 2017*
Figure 8 New Ablation Product Launches, 2013–2016
Figure 9 Data Triangulation Methodology
Figure 10 Ablation Technology Market Size, By Type (2016 vs 2021)
Figure 11 Ablation Technology Market Share, By Product (2016 vs 2021)
Figure 12 Ablation Technology Market Size, By Application (2016 vs 2021)
Figure 13 Ablation Technology Market Share, By Region (2016)
Figure 14 Rising Incidences of Cancer & Cardiac Diseases — Primary Driver of the Ablation Technology Market During
Figure 15 India and China are the Most Lucrative Markets for Ablation Product Manufacturers
Figure 16 U.S. Commanded the Largest Share of the Ablation Technology Market in 2016
Figure 17 Cardiovascular Disease Treatment Segment to Dominate the Ablation Technology Market in 2021
Figure 18 Radiofrequency Ablators Will Continue to Dominate the Market Till 2021
Figure 19 Global Ablation Technology Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Global Prevalence of Cancer: Expected Trend Till 2020
Figure 21 Ablation Technology Market: Porter’s Five Forces Analysis
Figure 22 Microwave Ablation Segment to Grow at the Highest CAGR During 2016 to 2021
Figure 23 Microwave Ablator is the Fastest-Growing Segment in the Global Ablation Technology Market
Figure 24 Cardiovascular Disease Treatment Ablation Market to Grow at the Highest CAGR in the Forecast Period
Figure 25 Number of Hip and Knee Replacement Surgeries, By Country: 2013
Figure 26 Global Ablation Technology Market Share, By Country (2016–2021)
Figure 27 North America: Ablation Technology Market Snapshot
Figure 28 Europe: Ablation Technology Market Snapshot
Figure 29 Asia-Pacific: Ablation Technology Market Snapshot
Figure 30 Leading Market Players Adopted New Product Launches & Approvals as Their Key Growth Strategy From 2013 to 2016
Figure 31 Global Ablation Technology Market Share, By Key Player, 2015
Figure 32 New Product Launches & Approvals Was the Key Strategy
Figure 33 Geographic Revenue Mix of Top Market Players
Figure 34 Medtronic PLC: Company Snapshot
Figure 35 Johnson and Johnson: Company Snapshot
Figure 36 St. Jude Medical, Inc.: Company Snapshot
Figure 37 Boston Scientific Corporation: Company Snapshot
Figure 38 Angiodynamics, Inc.: Company Snapshot
Figure 39 Atricure, Inc.: Company Snapshot
Figure 40 Conmed Corporation: Company Snapshot
Figure 41 Olympus Corporation: Company Snapshot
Figure 42 Smith & Nephew: Company Snapshot
Figure 43 BTG International Ltd. : Company Snapshot

The global ablation technology market is estimated to be valued at USD 2.82 Billion in 2016, growing at a CAGR of 10.9% between 2016 and 2021 and reach USD 4.73 Billion.

On the basis of type, the market is categorized into laser/light, radiofrequency, ultrasound, electrical, cryoablation, microwave, and hydrothermal ablation technology. The radiofrequency ablation segment is estimated to command the largest share of the global market in 2016 due to lower cost of radiofrequency ablation procedures as compared to other ablation techniques coupled with its high safety, efficacy, and short procedural duration for the treatment of cancer, atrial fibrillation, and pain management.

Based on products, the market is segmented into light/laser ablators, radiofrequency ablators, ultrasound ablators, electrical ablators, cryoablation devices, microwave ablators, and hydrothermal ablators. The microwave ablators segment is estimated to grow at the highest CAGR from 2016 to 2021. High success rate of microwave ablation in cancer treatment, as well as advantages offered by it over RF ablation (such as, microwave ablation devices can produce larger ablation zones and do not suffer as much from the heat sink effect that can handicap RF ablation), form the major factors contributing to the growth of this segment.

By application, the market is further segmented into cardiovascular disease, pain management, cancer, ophthalmology, cosmetic surgery, gynecology, urology, orthopedics, and others. The cardiovascular disease segment is estimated to account for the largest share of the market in 2016. Rising incidence of atrial fibrillation across the globe coupled with the development of novel ablation technology for the treatment of atrial fibrillation is the major factor driving the growth of the market.

North America is expected to command the largest share of the market in 2016, owing to the rapidly growing elderly population, high adoption rate of ablation devices in the region. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period. The significant growth reported by the APAC region is propelled by factors including the growing focus of global market players, the large population base, and the rising prevalence of cancer.

Ablation Technologies Market

Medtronic, plc (Ireland), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.), AtriCure, Inc. (U.S.), Smith & Nephew plc (U.K.), and Olympus Corporation (Japan) are some of the key players operating in the market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo